Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury

Trends in Cardiovascular Medicine

Volumn 13, Issue 2, 2003, Pages 72-79

  Bolli, Roberto ^a,b   Dawn, Buddhadeb ^a   Xuan, Yu Ting ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; JANUS KINASE; NITRIC OXIDE SYNTHASE; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN;

ENZYME ACTIVATION; ENZYME INDUCTION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REPERFUSION INJURY; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 0037315554     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(02)00230-X     Document Type: Review

References (44)

1. Bolli R. The late phase of preconditioning. Circ Res. 87:2000;972-983.
2. Bolli R., Bhatti Z.A., Tang X.L.et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 81:1997;42-52. a.
3. Bolli R., Dawn B., Tang X.L.et al. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol. 93:1998;325-338.
4. Bolli R., Dawn B., Xuan Y.T. Emerging role of the JAK-STAT pathway as a mechanism of protection against ischemia/reperfusion injury. J Mol Cell Cardiol. 33:2001;1893-1896.
5. Bolli R., Manchikalapudi S., Tang X.L.et al. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning Circ Res. 81:1997;1094-1107. b.
6. Chin Y.E., Kitagawa M., Kuida K.et al. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol. 17:1997;5328-5337.
7. Cohen M.V., Baines C.P., Downey J.M. Ischemic preconditioning. from adenosine receptor of KATP channel Annu Rev Physiol. 62:2000;79-109.
8. Darnell J.E. Jr. STATs and gene regulation. Science. 277:1997;1630-1635.
9. Dawn B., Xuan Y.T., Qiu Y.et al. Bifunctional role of protein tyrosine kinases in late preconditioning against myocardial stunning in conscious rabbits. Circ Res. 85:1999;1154-1163.
10. Guo Y., Jones W.K., Xuan Y.-T.et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the iNOS gene. Proc Natl Acad Sci USA. 96:1999;11,507-11,512.
11. Hattori R., Maulik N., Otani H.et al. Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol. 33:2001;1929-1936.
12. Heusch G. Nitroglycerin and delayed preconditioning in humans. yet another new mechanism for an old drug? Circulation. 103:2001;2876-2878.
13. Horvath C.M., Wen Z., Darnell J.E. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9:1995;984-994.
14. Imada K., Leonard W.J. The JAK-STAT pathway. Mol Immunol. 37:2000;1-11.
15. Kumar A., Commane M., Flickinger T.W.et al. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science. 278:1997;1630-1632.
16. Kunisada K., Hirota H., Fujio Y.et al. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Circulation. 94:1996;2626-2632.
17. Kuzuya T., Hoshida S., Yamashita N.et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 72:1993;1293-1299.
18. Leesar M.A., Stoddard M., Ahmed M.et al. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation. 95:1997;2500-2507.
19. Leesar M.A., Stoddard M.F., Dawn B.et al. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation. 103:2001;2935-2941.
20. Marber M.S., Latchman D.S., Walker J.M., Yellon D.M. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 88:1993;1264-1272.
21. Mascareno E., El-Shafei M., Maulik N.et al. JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation. 2001;104:2001;325-329.
22. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia. a delay of lethal cell injury in ischemic myocardium Circulation. 74:1986;1124-1136.
23. Negoro S., Kunisada K., Tone E.et al. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res. 47:2000;797-805.
24. Omura T., Yoshiyama M., Ishikura F.et al. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats. J Mol Cell Cardiol. 33:2001;307-316.
25. Pan J., Fukuda K., Kodama H.et al. Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart. Circ Res. 81:1997;611-617.
26. Ping P., Zhang J., Qiu Y.et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res. 81:1997;404-414.
27. Ping P., Zhang J., Zheng Y.T.et al. Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ Res. 85:1999;542-550.
28. Rizvi A., Tang X.L., Qiu Y.et al. Increased protein synthesis is necessary for the development of late preconditioning against myocardial stunning. Am J Physiol. 277:1999;H874-H884.
29. Schindler C., Darnell J.E. Jr. Transcriptional responses to polypeptide ligands. the JAK-STAT pathway Annu Rev Biochem. 64:1995;621-651.
30. Schindler C., Shuai K., Prezioso V.R., Darnell J.E. Jr. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science. 257:1992;809-813.
31. Schulz R., Cohen M.V., Behrends M.et al. Signal transduction of ischemic preconditioning. Cardiovasc Res. 52:2001;181-198.
32. Seidel H.M., Milocco L.H., Lamb P.et al. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA. 92:1995;3041-3045.
33. Shinmura K., Bolli R., Liu S.Q.et al. Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ Res. 91:2002;240-246.
34. Shinmura K., Tang X.L., Wang Y.et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA. 97:2000;10,197-10,202.
35. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem. 271:1996;33,157-33,160.
36. Stephanou A., Brar B.K., Scarabelli T.M.et al. Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J Biol Chem. 275:2000;10,002-10,008.
37. Sun J.Z., Tang X.L., Knowlton A.A.et al. Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest. 95:1995;388-403.
38. Sun J.Z., Tang X.L., Park S.W.et al. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 97:1996;562-576.
39. Wen Z., Zhong Z., Darnell J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241-250.
40. Wilks A.F. Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc Natl Acad Sci USA. 86:1989;1603-1607.
41. Xie Q., Whisnant R., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med. 177:1993;1779-1784.
42. Xuan Y.T., Guo Y., Han H.et al. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci USA. 98:2001;9050-9055.
43. Xuan Y.T., Guo Y., Zhu Y.et al. Mechanism of cyclooxygenase-2 upregulation in late preconditioning. J Mol Cell Cardiol. in press:2003.
44. Xuan Y.T., Tang X.L., Banerjee S.et al. Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res. 84:1999;1095-1109.